June, 2024
June 2024
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Karen Knudsen: Concerning disparities among Native Hawaiian and other Pacific Islanders
May 1, 2024, 20:31

Karen Knudsen: Concerning disparities among Native Hawaiian and other Pacific Islanders

Karen Knudsen shared a post by American Cancer Society on LinkedIn, adding:

“The AANHPI Cancer Facts & Figures report highlights concerning disparities, including that death rates for preventable cancers among Native Hawaiian and other Pacific Islanders are 2-3 times as high as white people.

Our hope is that this information leads to increased awareness around the importance of prevention and early detection through screening.

Learn more here.”

Quoting American Cancer Society’s post:

“Lung cancer is the leading cause of cancer death in Asian American, Native Hawaiian & other Pacific Islander (AANHPI) men. Learn more about key findings on how cancer impacts these individuals in the American Cancer Society’s first-ever Cancer Facts & Figures report focusing on the AANHPI population.”

American Cancer Society

Additional information.
Source: Karen Knudsen/LinkedIn and American Cancer Society/LinkedIn

Karen E. Knudsen is the CEO of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health. She also served as president for the Association of American Cancer Institutes (AACI), representing the 102 leading cancer centers in North America, and on the board of directors of the American Association for Cancer Research (AACR).

Dr. Knudsen currently holds leadership roles with some of the most important cancer entities in the United States. She serves on the board of advisors for the National Cancer Institute and on 12 external advisory boards for NCI-designated cancer centers. She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.
OncoDaily